Phase 1 Advanced / Metastatic Solid Tumor Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Recruiting
Phase 1
Study of ABO2102 in KRAS-Mutated Solid Tumors
Advanced / Metastatic Solid Tumor
Suzhou Abogen Biosciences Co., Ltd.101 enrolled1 locationNCT07455617
Recruiting
Phase 1
A Study of SR-8541A (ENPPI Inhibitor) in Advanced/Metastatic Solid Tumors
Advanced / Metastatic Solid Tumor
Stingray Therapeutics25 enrolled3 locationsNCT06063681